Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database

DSpace Repository

Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database

Author: Yan, Qingran; Bruni, Cosimo; Garaiman, Alexandru; Mihai, Carina; Jordan, Suzana; Becker, Mike Oliver; Elhai, Muriel; Dobrota, Rucsandra; Liubov, Petelytska; Henes, Joerg; Hachulla, Eric; Siegert, Elise; Balbir-Gurman, Alexandra; Cuomo, Giovanna; Riemekasten, Gabriela; Heitmann, Stefan; Beigi, Davide Mohammad Reza; Ullman, Susanne; Sfikakis, Petros; Ingegnoli, Francesca; Bernardino, Vera; Truchetet, Marie-Elise; Vonk, Madelon; Del Galdo, Francesco; Hoffmann-Vold, Anna-Maria; Shuang, Ye; Distler, Oliver
Tübinger Autor(en):
Henes, Jörg Christoph
Published in: Annals of The Rheumatic Diseases (2025), Bd. 84, H. 4, S. 620-631
Verlagsangabe: Amsterdam : Elsevier
Language: English
Full text: http://dx.doi.org/10.1016/j.ard.2025.01.014
ISSN: 0003-4967
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)